# Radiopharm Theranostics Ltd: financial statements, quarterly

RADX · Nasdaq · CIK 1949257 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/radx.md) · [Financials](/companies/radx/financials.md) · [Filings](/companies/radx/filings.md) · [Insiders](/companies/radx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/radx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2022-06-30) | period not labelled (2023-06-30) | period not labelled (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [27.0](/filings/0001213900-25-088699.md) | [11.7](/filings/0001213900-25-088699.md) | [18.6](/filings/0001213900-25-088699.md) | [29.1](/filings/0001213900-25-088699.md) |
| Current assets | $m | not reported | not reported | [22.8](/filings/0001213900-25-088699.md) | [39.9](/filings/0001213900-25-088699.md) |
| Total assets | $m | not reported | not reported | [72.0](/filings/0001213900-25-088699.md) | [86.5](/filings/0001213900-25-088699.md) |
| Current liabilities | $m | not reported | not reported | [17.6](/filings/0001213900-25-088699.md) | [14.9](/filings/0001213900-25-088699.md) |
| Total liabilities | $m | not reported | not reported | [44.7](/filings/0001213900-25-088699.md) | [43.6](/filings/0001213900-25-088699.md) |
| Shareholders' equity | $m | [63.0](/filings/0001213900-25-088699.md) | [45.6](/filings/0001213900-25-088699.md) | [27.4](/filings/0001213900-25-088699.md) | [42.9](/filings/0001213900-25-088699.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 3,544,216,160 at 2026-06-30, from the cover of the [20-F filed 2026-09-30](/filings/0001213900-26-105181.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.